22 Results for "

MPT

" in MedChemExpress (MCE) Product Catalog:
Products (22)

22 Results for "MPT" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-123976
CAS No.: 2151853-97-1
Purity:  99.79%
Target:  

HDAC

Research Areas:  

Neurological Disease Cancer

MPT0G211 is a potent, orally active and selective HDAC6 inhibitor (IC50=0.291 nM). MPT0G211 displays >1000-fold selective for HDAC6 over other HDAC isoforms. MPT0G211 can penetrate the blood-brain barrier. MPT0G211 ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model. MPT0G211 has anti-metastatic and neuroprotective effects. Anticancer activities .
loading...
    loading...
Cat. No.: HY-124295
CAS No.: 1338320-94-7
Purity:  99.40%
Synonyms: ABT-301; MPT0E028; TMU-C-0012
Target:  

HDAC Akt Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

Imofinostat (ABT-301; MPT0E028) is an orally active and selective HDAC inhibitor with IC50s of 53.0 nM, 106.2 nM, 29.5 nM for HDAC1, HDAC2 and HDAC6, respectively. Imofinostat has a weak inhibitory effect on HDAC8 (IC50 of 2.5 ​​μM), but no inhibitory effect on HDAC4 (IC50>10 μM). Imofinostat reduces the viability of B-cell lymphomas by inducing apoptosis and possesses potent direct Akt targeting ability and reduces Akt phosphorylation in B-cell lymphoma. Imofinostat has a broad-spectrum antitumor activity, including colorectal cancer, B-cell lymphoma, non-small cell lung carcinoma (NSCLC), and pancreatic cancer, while also showing therapeutic potential in non-tumor diseases like emphysema and pulmonary fibrosis .
loading...
    loading...
Cat. No.: HY-P3101
CAS No.: 1225021-13-5
Target:  

GCGR

GLP-1(28-36)amide, a C-terminal nonapeptide of GLP-1, is a major product derived from the cleavage of GLP-1 by the neutral endopeptidase (NEP). GLP-1(28-36)amide is an antioxidant and targets to mitochondrion, inhibits mitochondrial permeability transition (MPT). GLP-1(28-36)amide has anti-diabetic and cardioprotection effects .
loading...
    loading...
Cat. No.: HY-145426
CAS No.: 1817802-18-8
Purity:  98.76%
Target:  

HDAC

Research Areas:  

Cancer

MPT0B390 is an arylsulfonamide-based derivative with potent HDAC inhibitory ability. MPT0B390, TIMP3 inducer, inhibits tumor growth, metastasis and angiogenesis. MPT0B390 shows antiproliferative activity against human colon cancer cell line HCT116 with the GI50 of 0.03 μM .
loading...
    loading...
Cat. No.: HY-120786
CAS No.: 1215208-59-5
Purity:  99.67%
Synonyms: 6-(3′,4′,5′-Trimethoxybenzoyl)quinoline
Research Areas:  

Cancer

MPT0B014 is a tubulin polymerization inhibitor. MPT0B014 induces cancer cell apoptosis. MPT0B014 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-101287
CAS No.: 1346169-92-3
Purity:  99.63%
Research Areas:  

Cancer

MPT0B392, an orally active quinoline derivative, induces c-Jun N-terminal kinase (JNK) activation, leading to apoptosis. MPT0B392 inhibits tubulin polymerization and triggers induction of the mitotic arrest, followed by mitochondrial membrane potential loss and caspases cleavage by activation of JNK and ultimately leads to apoptosis. MPT0B392 is demonstrated to be a novel microtubule-depolymerizing agent and enhances the cytotoxicity of sirolimus in sirolimus-resistant acute leukemic cells and the multidrug resistant cell line .
loading...
    loading...
Cat. No.: HY-122888
CAS No.: 2070837-24-8
Research Areas:  

Cancer

MPT0L145 is a PIK3C3/FGFR inhibitor, with a Kd value of 0.53 nM for PIK3C3. MPT0L145 decreases the phosphorylation of FGFR1, FGFR3 and their downstream proteins (FRS2, ERK and Akt). MPT0L145 induces G0/G1 cell cycle arrest and decreased protein levels of cyclin E. MPT0L145 promotes mitochondrial dysfunction, ROS production, and DNA damage. MPT0L145 is an autophagy inhibitor. MPT0L145 significantly sensitizes cancer cells to targeted or chemotherapeutic agents. MPT0L145 can be used for cancer research, such as bladder cancer and NSCLC .
loading...
    loading...
Cat. No.: HY-P2996B
CAS No.: 9029-27-0
Target:  

Others

Research Areas:  

Others

Nitrate Reductase (NAD[P]H), Pichia pastoris (recombinant) is a simplified version of nitrate reductase S-NaR1 expressed and purified by Pichia pastoris. Nitrate Reductase (NAD[P]H), Pichia Pastoris (recombinant) contains sites binding molybdenum-molybdenopyridine (Mo-MPT) and nitrate reduction active sites and only contains two domains instead of the five domains of the complete NaR. This simplified form of nitrate reductase was expressed in high density in P. pastoris and purified to homogeneity in one step by fixed metal affinity chromatography (IMAC). Nitrate Reductase (NAD[P]H), Pichia Pastoris (recombinant) can be used in the development of biosensors and environmental monitoring .
loading...
    loading...
Cat. No.: HY-141541
CAS No.: 2241643-23-0
Target:  

HDAC Tau Protein

Research Areas:  

Neurological Disease

MPT0G413 (Compound 6) is a potent, selective, orally active and brain-penetrant HDAC6 inhibitor with an IC50 of 3.92 nM. MPT0G413 decreases not only the level of phosphorylation of tau proteins but also the aggregation of tau proteins. MPT0G413 can ameliorate the impaired learning and memory. MPT0G413 can be used for the research of neurological disease, such as Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-138289
CAS No.: 2173386-55-3
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

4-acetoxy MPT is a tryptamine that induces the head-twitch response (HTR) in mice .
loading...
    loading...
Cat. No.: HY-D0129
CAS No.: 82962-86-5
Synonyms: MPTS
Target:  

Fluorescent Dye

Research Areas:  

Others

8-Methoxypyrene-1,3,6-trisulfonate trisodium (MPTS) is a highly water-soluble superpolar fluorescent probe .
loading...
    loading...
Cat. No.: HY-163269
CAS No.: 2413282-48-9
Target:  

Bacterial

Research Areas:  

Others

MPT is a novel and highly efficient nitrification inhibitor. MPT inhibits ammoniaoxidizing bacteria and archaea .
loading...
    loading...
Cat. No.: HY-170053
CAS No.: 763035-03-6
Synonyms: 4-OH-MPT; Meprocin
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

4-Hydroxy MPT (4-OH-MPT), a serotonergic hallucinogen, is a 5-HT2A and 5-HT2B receptors agonist with EC50 values of 3.82 nM and 3.4 nM, respectively .
loading...
    loading...
Cat. No.: HY-123976A
CAS No.: 2151854-33-8
Target:  

HDAC

Research Areas:  

Neurological Disease Cancer

MPT0G211 mesylate is a potent, orally active and selective HDAC6 inhibitor (IC50=0.291 nM). MPT0G211 mesylate displays >1000-fold selective for HDAC6 over other HDAC isoforms. MPT0G211 mesylate can penetrate the blood-brain barrier. MPT0G211 mesylate ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model. MPT0G211 mesylate has anti-metastatic and neuroprotective effects. Anticancer activities .
loading...
    loading...
Cat. No.: HY-124083
CAS No.: 1215208-65-3
MPT0B214 is a microtubule inhibitor that strongly binds to the colchicine binding site of tubulin, preventing tubulin polymerization. MPT0B214 induces apoptosis through a mitochondrial/caspase 9 dependent pathway and shows cytotoxicity across various human tumor cell lines. MPT0B214 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-122151
CAS No.: 946077-08-3
Research Areas:  

Cancer

MPT0B002 is a potent microtubule inhibitor with anticancer activities. MPT0B002 disrupts tubulin polymerization, induces apoptosis, and arrests cell cycle at the G2/M phase .
loading...
    loading...
Cat. No.: HY-P3101A
Target:  

GCGR

GLP-1(28-36)amide TFA, a C-terminal nonapeptide of GLP-1, is a major product derived from the cleavage of GLP-1 by the neutral endopeptidase (NEP). GLP-1(28-36)amide TFA is an antioxidant and targets to mitochondrion, inhibits mitochondrial permeability transition (MPT). GLP-1(28-36)amide TFA has anti-diabetic and cardioprotection effects .
loading...
    loading...
Cat. No.: HY-101287R
CAS No.: 1346169-92-3
MPT0B392 (Standard) is the analytical standard of MPT0B392 (HY-101287). This product is intended for research and analytical applications. MPT0B392, an orally active quinoline derivative, induces c-Jun N-terminal kinase (JNK) activation, leading to apoptosis. MPT0B392 inhibits tubulin polymerization and triggers induction of the mitotic arrest, followed by mitochondrial membrane potential loss and caspases cleavage by activation of JNK and ultimately leads to apoptosis. MPT0B392 is demonstrated to be a novel microtubule-depolymerizing agent and enhances the cytotoxicity of sirolimus in sirolimus-resistant acute leukemic cells and the multidrug resistant cell line .
loading...
    loading...
Cat. No.: HY-124595
CAS No.: 1254363-89-7
MPT0B098 is a microtubule inhibitor with a Ki of 0.8 μM and an IC50 of 0.8 μM. MPT0B098 inhibits tubulin polymerization, blocks HuR nuclear-cytoplasmic translocation to decrease HIF-1α mRNA stability, suppresses HIF-1α, TGF-β/Smad, JAK2/STAT3 and FAK/actin cytoskeleton signaling pathways, upregulates SOCS3 to reinforce the inhibition of JAK2/STAT3 cascade, and induces apoptosis. MPT0B098 can be used for research on multiple malignancies including head and neck squamous cell carcinoma and human non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-P705686
Purity:  ≥ 85%, as determined by reducing SDS-PAGE .
Synonyms: MPT64; MT2032; Immunogenic protein MPT64; Antigen MPT64
Species:  
Source:  
loading...
    loading...